Related Experiment Videos
Strenuous exercise simulating hepatic injury during vaccine trials
1Virology Division, US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702-5011.
Vaccine
|January 1, 1992
Summary
Strenuous physical training can cause temporary increases in serum transaminase levels in healthy individuals. Researchers recommend that clinical trial participants avoid strenuous exercise before blood tests to ensure accurate results.
Area of Science:
- Biochemistry
- Clinical Trials
- Exercise Physiology
Background:
- Phase 1 clinical vaccine trials require careful monitoring of participant health.
- Serum transaminase levels are common biomarkers for assessing liver function and potential injury.
- Unexplained elevations in these enzymes prompted an investigation into potential confounding factors.
Observation:
- Three healthy male volunteers in a vaccine trial exhibited elevated serum transaminase levels.
- These elevations correlated with strenuous physical training undertaken 2-5 days prior.
- A key observation was the parallel increase in creatine phosphokinase, an enzyme primarily associated with muscle damage.
Findings:
- The pattern of serum enzyme elevations was not indicative of hepatic injury but rather associated with muscle exertion.
- A controlled re-exposure to strenuous exercise in one participant replicated the enzyme elevation pattern.
- This suggests that intense physical activity can transiently alter serum enzyme profiles.
Implications:
- It is crucial to consider recent physical activity when interpreting serum enzyme levels in clinical trials.
- Participants in studies measuring serum enzymes should be advised to maintain their usual activity levels.
- This finding helps differentiate exercise-induced changes from potential drug-induced liver injury, improving trial safety and data integrity.